Acquisition of a second Cannula Technology from UCLA
February 20 2018
Spectrum Medical is pleased to announce
that it has acquired a second exclusive licensing agreement with the University
of California, Los Angeles (UCLA) Technology Development Group on behalf of UC
Regents. The license relates to intellectual property that supports clinical
applications requiring Extracorporeal Circulation to support pulmonary gas
exchange functions (ECMO) and/or circulatory support of the left heart.
“Spectrum
Medical is particularly proud to have been selected by UCLA for a second
partnership on this exciting new technology which now completes the development
of a complete product strategy that will deliver in the medium term a unique
full systems approach to the management of extracorporeal circulation, left
heart and right heart ventricular support” said Steve Turner, Spectrum Medical
CEO. “All of us at Spectrum Medical are committed to the advancement of both
the practice and care of critically ill patients around the world and to the
UCLA partnership”.